Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CGC NASDAQ:CRON OTCMKTS:STDAF NASDAQ:TLRY NYSE:USNA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCGCCanopy Growth$1.01-1.0%$1.08$0.84▼$2.38$412.21M0.777.36 million shs3.53 million shsCRONCronos Group$2.74-1.8%$2.67$1.84▼$3.43$1.04B0.891.39 million shs758,640 shsSTDAFSTADA Arzneimittel Aktiengesellschaft$110.42$110.42$75.15▼$115.00$6.88B0.38180 shsN/ATLRYTilray Brands$5.02-2.9%$5.99$3.51▼$23.20$602.56M1.883.35 million shs3.13 million shsUSNAUSANA Health Sciences$19.21+1.1%$18.50$16.60▼$38.32$350.98M0.76114,731 shs101,295 shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCGCCanopy Growth-0.98%-1.46%-9.82%-2.88%-32.67%CRONCronos Group-1.79%+1.11%-0.36%+10.04%+40.51%STDAFSTADA Arzneimittel Aktiengesellschaft0.00%0.00%0.00%0.00%0.00%TLRYTilray Brands-2.90%-1.76%-8.89%-27.77%+19.61%USNAUSANA Health Sciences+0.68%+9.99%+10.08%+11.73%-37.62%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCGCCanopy Growth$1.01-1.0%$1.08$0.84▼$2.38$412.21M0.777.36 million shs3.53 million shsCRONCronos Group$2.74-1.8%$2.67$1.84▼$3.43$1.04B0.891.39 million shs758,640 shsSTDAFSTADA Arzneimittel Aktiengesellschaft$110.42$110.42$75.15▼$115.00$6.88B0.38180 shsN/ATLRYTilray Brands$5.02-2.9%$5.99$3.51▼$23.20$602.56M1.883.35 million shs3.13 million shsUSNAUSANA Health Sciences$19.21+1.1%$18.50$16.60▼$38.32$350.98M0.76114,731 shs101,295 shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCGCCanopy Growth-0.98%-1.46%-9.82%-2.88%-32.67%CRONCronos Group-1.79%+1.11%-0.36%+10.04%+40.51%STDAFSTADA Arzneimittel Aktiengesellschaft0.00%0.00%0.00%0.00%0.00%TLRYTilray Brands-2.90%-1.76%-8.89%-27.77%+19.61%USNAUSANA Health Sciences+0.68%+9.99%+10.08%+11.73%-37.62%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCGCCanopy Growth 2.17HoldN/AN/ACRONCronos Group 2.20Hold$2.30-16.06% DownsideSTDAFSTADA Arzneimittel Aktiengesellschaft 0.00N/AN/AN/ATLRYTilray Brands 2.25Hold$11.50129.08% UpsideUSNAUSANA Health Sciences 1.50ReduceN/AN/ACurrent Analyst Ratings BreakdownLatest CGC, TLRY, STDAF, CRON, and USNA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/1/2026CGCCanopy Growth Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/29/2026CRONCronos Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D+)5/18/2026CGCCanopy Growth Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/13/2026TLRYTilray Brands Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/12/2026CRONCronos Group TD SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy5/4/2026CGCCanopy Growth Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)4/29/2026TLRYTilray Brands Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)4/22/2026USNAUSANA Health Sciences Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold4/20/2026CGCCanopy Growth Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/13/2026USNAUSANA Health Sciences Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy4/2/2026TLRYTilray Brands ATB Cormark Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetSector Perform$9.50 ➝ $9.00(Data available from 6/11/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCGCCanopy Growth$225.65M1.81N/AN/A$1.90 per share0.53CRONCronos Group$146.59M6.97$0.01 per share222.54$3.00 per share0.91STDAFSTADA Arzneimittel Aktiengesellschaft$3.84B1.79$11.12 per share9.93$23.11 per share4.78TLRYTilray Brands$210.48M2.78$1.40 per share3.58$14.04 per share0.36USNAUSANA Health Sciences$925.26M0.38$4.18 per share4.60$29.16 per share0.66Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCGCCanopy Growth-$429.86M-$1.30N/AN/AN/A-94.39%-46.85%-28.95%6/15/2026 (Confirmed)CRONCronos Group-$9.45M$0.01274.27N/AN/A-1.14%-1.26%-1.20%8/6/2026 (Estimated)STDAFSTADA Arzneimittel Aktiengesellschaft$292.15MN/AN/AN/AN/AN/AN/AN/AN/ATLRYTilray Brands-$2.19B-$13.65N/AN/AN/A-156.51%-3.31%-2.42%7/27/2026 (Estimated)USNAUSANA Health Sciences$10.76M$0.4740.876.940.750.96%6.21%4.50%7/28/2026 (Estimated)Latest CGC, TLRY, STDAF, CRON, and USNA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/15/2026Q4 2026CGCCanopy Growth-$0.06N/AN/AN/A$53.43 millionN/A5/11/2026Q1 2026CRONCronos Group$0.01$0.01N/A$0.04$42.20 million$58.97 million5/5/2026Q1 2026USNAUSANA Health Sciences$0.44$0.61+$0.17$0.41$240.99 million$250.22 million4/1/2026Q3 2026TLRYTilray Brands-$0.14-$0.24-$0.10-$0.24$201.35 million$206.73 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCGCCanopy GrowthN/AN/AN/AN/AN/ACRONCronos GroupN/AN/AN/AN/AN/ASTDAFSTADA Arzneimittel AktiengesellschaftN/AN/AN/AN/AN/ATLRYTilray BrandsN/AN/AN/AN/AN/AUSNAUSANA Health SciencesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCGCCanopy Growth0.305.344.26CRONCronos GroupN/A21.8720.73STDAFSTADA Arzneimittel Aktiengesellschaft2.231.540.99TLRYTilray Brands0.192.791.66USNAUSANA Health SciencesN/A2.511.69Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCGCCanopy Growth3.33%CRONCronos Group8.71%STDAFSTADA Arzneimittel AktiengesellschaftN/ATLRYTilray Brands9.35%USNAUSANA Health Sciences54.25%Insider OwnershipCompanyInsider OwnershipCGCCanopy Growth0.16%CRONCronos Group7.80%STDAFSTADA Arzneimittel AktiengesellschaftN/ATLRYTilray Brands0.84%USNAUSANA Health Sciences0.82%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCGCCanopy Growth3,150404.12 million403.48 millionOptionableCRONCronos Group450373.03 million343.94 millionOptionableSTDAFSTADA Arzneimittel Aktiengesellschaft12,50062.34 millionN/ANot OptionableTLRYTilray Brands2,842116.55 million115.57 millionOptionableUSNAUSANA Health Sciences1,57018.46 million18.31 millionOptionableCGC, TLRY, STDAF, CRON, and USNA HeadlinesRecent News About These CompaniesAre Investors Undervaluing USANA Health Sciences (USNA) Right Now?June 10 at 10:41 AM | zacks.comUSANA's Celavive Contouring Face & Neck Crème Named Among Canada's Top Skincare ProductsJune 8 at 1:35 PM | finance.yahoo.comUSANA Earns Dual Best of State Honors for Product Innovation and DevelopmentJune 4, 2026 | prnewswire.comUSANA Health Sciences (NYSE:USNA) Director Sells $43,928.50 in StockJune 2, 2026 | insidertrades.com1 stock under $50 with promising prospects and 2 we brush offJune 1, 2026 | msn.comKevin Guest Encourages Professionals to Prioritize Wellness During Professional Wellness MonthJune 1, 2026 | prnewswire.comUSANA Health Sciences (NYSE:USNA) CFO Sells $100,500.00 in StockMay 29, 2026 | insidertrades.comUSANA Health Sciences (NYSE:USNA) Director Gilbert Fuller Sells 1,057 SharesMay 27, 2026 | insidertrades.comShould Value Investors Buy USANA Health Sciences (USNA) Stock?May 25, 2026 | zacks.com4 Top Value Stocks to Buy Now as Wall Street Takes Fresh NoticeMay 22, 2026 | zacks.comUSNA or SDZNY: Which Is the Better Value Stock Right Now?May 12, 2026 | zacks.comInsider Selling: USANA Health Sciences (NYSE:USNA) Insider Sells 3,791 Shares of StockMay 9, 2026 | insidertrades.comUSANA Health (USNA) Upgraded to Buy: What Does It Mean for the Stock?May 8, 2026 | zacks.comShould Value Investors Buy USANA Health Sciences (USNA) Stock?May 8, 2026 | zacks.comUSANA Health Sciences, Inc. Just Recorded A 78% EPS Beat: Here's What Analysts Are Forecasting NextMay 8, 2026 | finance.yahoo.comUSANA Health: Q1 Earnings SnapshotMay 7, 2026 | chron.comUSANA's People-First Culture Earns Spot on USA TODAY Top Workplaces ListMay 7, 2026 | prnewswire.comUSANA (NYSE:USNA) Delivers Impressive Q1 CY2026May 7, 2026 | finance.yahoo.comUSANA (USNA) Q1 2026 Earnings Call TranscriptMay 7, 2026 | aol.comAUSANA Health Sciences Signals Confident 2026 Growth PathMay 6, 2026 | tipranks.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All Headlines5 Stocks Winning the AI Race While Everyone Watches NVIDIABy Bridget Bennett | May 26, 20263 Stocks Rallying on Micron's Price Boost: Substance or Hype?By Dan Schmidt | May 28, 2026The DRAM Shake-Up: Samsung Stumbles, Micron Chases $1000By Jeffrey Neal Johnson | May 12, 2026Micron’s $1 Trillion Memory Melt-UpBy Jeffrey Neal Johnson | May 27, 2026Micron Investors Face a High-Stakes Moment After the Latest RallyBy Thomas Hughes | May 13, 2026CGC, TLRY, STDAF, CRON, and USNA Company DescriptionsCanopy Growth NASDAQ:CGC$1.01 -0.01 (-0.98%) Closing price 06/10/2026 04:00 PM EasternExtended Trading$1.01 +0.00 (+0.50%) As of 06/10/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices. It sells its products under the Tweed, 7ACRES, DOJA, Deep Space, HiWay, Maitri, Twd., Vert, Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Martha Stewart, and Wana brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.Cronos Group NASDAQ:CRON$2.74 -0.05 (-1.79%) Closing price 06/10/2026 04:00 PM EasternExtended Trading$2.72 -0.02 (-0.55%) As of 06/10/2026 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.STADA Arzneimittel Aktiengesellschaft OTCMKTS:STDAF$110.42 0.00 (0.00%) As of 10/24/2022STADA is a publicly traded, international company with a focus on the healthcare market, especially the pharmaceutical and in particular the generics market.Tilray Brands NASDAQ:TLRY$5.02 -0.15 (-2.90%) Closing price 06/10/2026 04:00 PM EasternExtended Trading$5.03 +0.01 (+0.12%) As of 06/10/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.USANA Health Sciences NYSE:USNA$19.21 +0.20 (+1.05%) Closing price 06/10/2026 03:59 PM EasternExtended Trading$19.17 -0.04 (-0.21%) As of 06/10/2026 04:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The Biggest Opportunity From SpaceX’s IPO May Surprise You Chewy’s Growth Engine Is Stronger Than the Market Thinks Everpure: AI Storage Uncertainty Overshadows Breakneck Growth This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason FuelCell Energy Just Got a Wake-Up Call From Wall Street Intel Is the Market's Most Mispriced AI Hedge Palantir's AIPCon Shows Why Customers Are Fueling the Bull Case Uranium Energy Corp Melts Down—Nuclear Opportunity at Hand Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
